Coated Particulate Form (e.g., Liposome, Etc.) Patents (Class 424/417)
  • Patent number: 7927617
    Abstract: The invention relates to preparations, in particular plant-protective preparations which contain a mixture of at least two different active plant-protective substances, wherein a) at least one active substance is selected from a conazole group (active substance 1) and b) another active-plant protective substance (active substance 2) whose water solubility at a temperature of 20° C. is less than 20 g/l., c) at least one type of copolymer CP consisting of M monomers comprising ?) at least one type of monoethylenically unsaturated monomer M1 comprising at least one sulphonic acid group and ?) at least one type of neutral monoethylenically unsaturated monomer M2, wherein the quantitative ratio between the active substance 1 and the other active plant-protective substance 2 ranges from 1:10 to 10:1.
    Type: Grant
    Filed: April 13, 2006
    Date of Patent: April 19, 2011
    Assignee: BASF Aktiengesellschaft
    Inventors: Sebastian Koltzenburg, Peter Dombo, Günter Oetter, Christian Krüger, Wolfgang Schrof, Matthias Bratz
  • Patent number: 7927811
    Abstract: The present invention relates to polypeptides having a brain-localizing activity, molecules comprising these polypeptides, and pharmaceutical agents that confer brain-localizing activity. The present inventors are the first to reveal amino acid motif sequences involved in brain-localizing activity. Polypeptides that comprise such motif sequences and have brain localizing activity were discovered as follows: DNAs encoding polypeptides comprising random amino acid sequences were synthesized, and incorporated into a phage library. The phage library produced was used to screen for polypeptides having brain-localized activity, which yielded such several polypeptides. These polypeptides comprised common sequences, which lead to the successful discovery of amino acid motif sequences involved in brain-localizing activity.
    Type: Grant
    Filed: August 6, 2004
    Date of Patent: April 19, 2011
    Assignee: Proteus Sciences Co., Ltd.
    Inventor: Makoto Sawada
  • Publication number: 20110052656
    Abstract: A process has been found which increases the efficiency and effectiveness of introducing antimicrobial compounds into complex biofilm matrices through the use of liposome carriers, thereby removing the biofouling in industrial water bearing systems, including piping, heat exchanges, condensers, filtration systems and fluid storage tanks. According to one embodiment of the invention, antimicrobial compound containing liposomes are added to water systems prone to biofouling and biofilm formation. The liposomes, being similar in composition to microbial membranes or cells, are readily incorporated into the existing biofilm. Once the antimicrobial compound containing liposomes become entrained with the biofilm matrix, the decomposition or programmed disintegration of the liposome proceeds. Thereafter, the biocidal aqueous core is released to react directly with the biofilm encased microorganisms.
    Type: Application
    Filed: September 28, 2010
    Publication date: March 3, 2011
    Applicant: GENERAL ELECTRIC COMPANY
    Inventors: Wilson Kurt Whitekettle, Gloria Jean Tafel, Qing Zhao, Linna Wang, Dorothy Reynolds, Paul Frail, Juan Jiang, David M. Polizzotti
  • Patent number: 7887828
    Abstract: The present invention discloses systems and methods for controlling arthropod populations. The systems include a polymeric substrate, a semiochemical that is reactive upon an adult-stage arthropod, and an insecticide that is toxic to an immature-stage arthropod. The semiochemical may be a sex pheromone that disrupts mating behavior of the adult-stage arthropod. The insecticide may be a per os insecticide that only affects the immature-stage arthropod. The arthropod to be controlled may be gypsy moths, in which case the semiochemical may be disparlure and the insecticide may be spinosad. Further disclosed are methods for preparing systems for use in controlling arthropod populations.
    Type: Grant
    Filed: November 6, 2007
    Date of Patent: February 15, 2011
    Assignee: ISCA Technologies, Inc.
    Inventor: Agenor Mafra-Neto
  • Patent number: 7851459
    Abstract: The present invention relates to methods for diluting water-stable organosilane compositions comprising an organosilane, optionally having a non-hydrolyzable organic group, but having one or more hydrolyzable groups, and an acidified stabilizing solution prepared from at least one acid, and at least one cationic surfactant, preferably at least one quaternary ammonium salt (QAS), in water. The organosilane composition is diluted with a glycol ether. The resultant diluted organosilane composition may be used to antimicrobially treat a substrate.
    Type: Grant
    Filed: September 3, 2008
    Date of Patent: December 14, 2010
    Assignee: Vitec Speciality Chemicals Limited
    Inventors: Robert McMahon, William Crook
  • Patent number: 7842288
    Abstract: A marine anti-bio-fouling coating 10, for application onto the surface of a marine article 12. The coating 10 comprises a self-levelling, self-curing epoxy resin primer adhesive 14, an adhesive modified epoxy resin binder adhesive 16 and granulated Copper Nickel alloy 18. When a coated marine article 12 is immersed in water a chemical reaction occurs between the water and the Copper Nickel alloy 18 which causes a film of a complex metal oxide 20 to form on the exterior surface of the layer of Copper Nickel alloy granules 18. The oxide film 20 forms an inhospitable environment to aquatic organisms and aquatic borers, thereby preventing bio-fouling occurring on the coated marine article. A method of applying the coating 10 to a marine article 12 is also provided.
    Type: Grant
    Filed: December 10, 2004
    Date of Patent: November 30, 2010
    Inventor: Gareth Weed
  • Patent number: 7842195
    Abstract: Methods and compositions to a clathrate that includes chlorine dioxide (ClO2) are provided. Clathrates trap gaseous chlorine dioxide to provide a dry solid material that is stable and easy to use and handle. Stable formulations of gaseous chlorine dioxide are useful as disinfectants.
    Type: Grant
    Filed: July 2, 2007
    Date of Patent: November 30, 2010
    Inventor: Joseph Callerame
  • Patent number: 7824557
    Abstract: A process has been found which increases the efficiency and effectiveness of introducing antimicrobial compounds into complex biofilm matrices through the use of liposome carriers, thereby removing the biofouling in industrial water bearing systems, including piping, heat exchanges, condensers, filtration systems and fluid storage tanks. According to one embodiment of the invention, antimicrobial compound containing liposomes are added to water systems prone to biofouling and biofilm formation. The liposomes, being similar in composition to microbial membranes or cells, are readily incorporated into the existing biofilm. Once the antimicrobial compound containing liposomes become entrained with the biofilm matrix, the decomposition or programmed disintegration of the liposome proceeds. Thereafter the biocidal aqueous core is released to react directly with the biofilm encased microorganisms.
    Type: Grant
    Filed: August 8, 2007
    Date of Patent: November 2, 2010
    Assignee: General Electric Company
    Inventors: Wilson Kurt Whitekettle, Gloria Jean Tafel, Qing Zhao
  • Patent number: 7785478
    Abstract: A method for controlling protozoa trophozites and cysts wherein biocides or control agents are encapsulated within microcapsules or manufactured into the core of liposomes, thereafter the biocide containing microcapsules or liposomes are then introduced into an aqueous system.
    Type: Grant
    Filed: August 8, 2007
    Date of Patent: August 31, 2010
    Assignee: General Electric Company
    Inventors: Wilson Kurt Whitekettle, Gloria Jean Tafel
  • Patent number: 7754655
    Abstract: The invention relates to novel microcapsule formulations of (A) a particulate disperse phase of microcapsules comprising (1) a polyurea and/or polyurethane coating with average layer thicknesses of between 5 and 20 nm, and (2) a capsule filling comprising at least one penetrant and, optionally, additives, and (B) a suspension comprising (1) at least one solid agrochemical active compound, (2) additives, (3) water, and (4) optionally, one or more agrochemical active compounds that are liquid at room temperature. The invention further relates to a process for the preparation of these microcapsule formulations and to their use for applying agrochemical active compounds.
    Type: Grant
    Filed: May 16, 2003
    Date of Patent: July 13, 2010
    Assignee: Bayer Cropscience AG
    Inventors: Hilmar Wolf, Peter Baur, Manfred Zimmermann
  • Patent number: 7749491
    Abstract: Agents and methods to alter rAAV transduction are provided.
    Type: Grant
    Filed: March 31, 2004
    Date of Patent: July 6, 2010
    Assignees: University of Iowa Research Foundation, Targeted Genetics Corporation
    Inventors: John F. Engelhardt, Keith L. Munson, Ziying Yan
  • Patent number: 7722855
    Abstract: The invention relates to membrane vesicles from non-pathogenic amoeba, in particular from the amoeba Dictyostelium discoideum, containing a molecule of therapeutic interest, to a method of preparing such vesicles and to the use of said vesicles as a vehicle for transferring the molecule therapeutic interest to an eukaryotic mammalian cell.
    Type: Grant
    Filed: July 13, 2004
    Date of Patent: May 25, 2010
    Assignee: Universite Pierre et Marie Curie-Paris VI
    Inventors: Irène Tatischeff, Annette Alfsen, Françoise Lavialle
  • Patent number: 7723311
    Abstract: A system for introducing a bioactive substance into a target cell within a body. The bioactive substance is transported to the target cell using a superparamagnetic nanoparticle and a controllable magnetic field generator that is capable of moving the nanoparticle to the target cell through the body in three dimensions. The nanoparticle may be covered with a biocompatible shell that forms a covalent bond with the bioactive substance. In an alternative embodiment, the bioactive substance and a plurality of nanoparticles are supported by a bioerodable matrix that forms a nanosphere. The nanosphere may be moved into the target cell using an external magnetic field that is controllable to move the nanosphere in three dimensions through the body and the bioactive substance is released from the nanosphere once inside the target cell.
    Type: Grant
    Filed: June 18, 2004
    Date of Patent: May 25, 2010
    Assignees: The United States of America as represented by the Secretary of the Navy
    Inventors: Charles E. Seeney, Kenneth J. Dormer, Richard D. Kopke
  • Patent number: 7718190
    Abstract: Certain diacylglycerol-polyethyleneglycol (DAG-PEG) lipids are especially useful for forming thermodynamically stable liposomes. Such liposomes are useful for a variety of purposes, including the delivery of therapeutic agents.
    Type: Grant
    Filed: October 24, 2006
    Date of Patent: May 18, 2010
    Inventors: Brian Charles Keller, Danilo Lasic, Alenka Lasic, legal representative
  • Patent number: 7682823
    Abstract: The present invention provides novel bioreactor systems, adapted to provide continuous batch incubation of microbes, especially bacteria. The bioreactor bags are preloaded with dry, inert microbes prior to being shipped to the user. Multiple sterile, preloaded, disposable bioreactor bags are used in a self-contained housing. The bags are automatically incubated in the housing and dispensed, preferably into an irrigation system. The system will provide serial batch production of useful microbes for a week or more, without further supervision or intervention. Methods of manufacture, methods of use, methods of sales, and methods of farming are also provided.
    Type: Grant
    Filed: January 4, 2006
    Date of Patent: March 23, 2010
    Inventor: Larry Runyon
  • Publication number: 20100047304
    Abstract: The present invention relates to micro-sized particles having anti-biocontaminant properties. Each particle is comprised of a central metal core, or support structure, (for example, alumina oxide) and has on its surface, one or more anti-biocontaminant metals and at least one redox agent.
    Type: Application
    Filed: November 2, 2009
    Publication date: February 25, 2010
    Inventors: Mark Moskovitz, Chris McDow
  • Patent number: 7658939
    Abstract: Disclosed is an oral dosage form comprising (i) an opioid agonist in releasable form and (ii) a sequestered opioid antagonist which is substantially not released when the dosage form is administered intact.
    Type: Grant
    Filed: November 4, 2003
    Date of Patent: February 9, 2010
    Assignee: Purdue Pharma L.P.
    Inventors: Benjamin Oshlack, Curtis Wright, J. David Haddox
  • Patent number: 7651770
    Abstract: The present invention discloses a nano-cluster that includes a plurality of nano-particles, wherein the nano-particles can disperse in response to an environmental cue. Also disclosed is a method of preventing, treating, or diagnosing a disease or condition in a subject comprising administering a therapeutically effective amount of a composition comprising nano-clusters of the present invention.
    Type: Grant
    Filed: December 14, 2006
    Date of Patent: January 26, 2010
    Assignee: The University of Kansas
    Inventors: Cory J. Berkland, Lianjun Shi
  • Patent number: 7635675
    Abstract: Fatty acid salt particles having a size distribution wherein the particles are from about 1 to about 1,000 microns in diameter, use of the particles in pharmaceutical compositions, as well as methods of making and using the particles and compositions.
    Type: Grant
    Filed: August 13, 2004
    Date of Patent: December 22, 2009
    Assignee: Biocon Limited
    Inventors: Foyeke Opawale, Richard Soltero
  • Patent number: 7629001
    Abstract: Volatile impregnated substrates, such as wicks and mats, that can be used in a dispensing device that uses a heat source or otherwise uses active means to promote the release of the volatile material from the substrate are disclosed. The preferred substrate has a structure including sand particles adhered together by a binder to form a network of pores and passages. The binder is selected from thermoset polymeric materials and mixtures thereof. A volatile material is disposed in the pores before the substrate is installed in the dispensing device. The impregnated substrate is positioned in the dispensing device on or near the heat source of the dispensing device. The heat source is activated thereby elevating the temperature of the substrate such that volatile material is released from the pores. In one embodiment, the sand particles comprise silica sand and the binder is a cured novolac resin.
    Type: Grant
    Filed: April 15, 2005
    Date of Patent: December 8, 2009
    Assignee: S.C. Johnson & Son, Inc.
    Inventors: Brian T. Davis, Robert R. Emmrich, Michael J. Aulozzi, Padma Prabodh Varanasi, Michael C. Fryan, Kenneth J. Welch, Stanley J. Flashinski, Debra A. Strasser
  • Patent number: 7625578
    Abstract: Volatile impregnated substrates, such as wicks and mats, that can be used in a dispensing device that uses a heat source or otherwise uses active means to promote the release of the volatile material from the substrate are disclosed. The preferred substrate has a structure including sand particles adhered together by a binder to form a network of pores and passages. The binder is selected from thermoset polymeric materials and mixtures thereof. A volatile material is disposed in the pores before the substrate is installed in the dispensing device. The impregnated substrate is positioned in the dispensing device on or near the heat source of the dispensing device. The heat source is activated thereby elevating the temperature of the substrate such that volatile material is released from the pores. In one embodiment, the sand particles comprise silica sand and the binder is a cured novolac resin.
    Type: Grant
    Filed: April 15, 2005
    Date of Patent: December 1, 2009
    Assignee: S. C. Johnson & Son, Inc.
    Inventors: Brian T. Davis, Robert R. Emmrich, Michael J. Aulozzi, Padma Prabodh Varanasi, Michael C. Fryan, Kenneth J. Welch, Stanley J. Flashinski, Debra A. Strasser
  • Patent number: 7622134
    Abstract: Volatile impregnated substrates, such as wicks and mats, that can be used in a dispensing device that uses a heat source or otherwise uses active means to promote the release of the volatile material from the substrate are disclosed. The preferred substrate has a structure including sand particles adhered together by a binder to form a network of pores and passages. The binder is selected from thermoset polymeric materials and mixtures thereof. A volatile material is disposed in the pores before the substrate is installed in the dispensing device. The impregnated substrate is positioned in the dispensing device on or near the heat source of the dispensing device. The heat source is activated thereby elevating the temperature of the substrate such that volatile material is released from the pores. In one embodiment, the sand particles comprise silica sand and the binder is a cured novolac resin.
    Type: Grant
    Filed: October 21, 2005
    Date of Patent: November 24, 2009
    Assignee: S.C. Johnson & Son, Inc.
    Inventors: Brian T. Davis, Robert R. Emmrich, Michael J. Aulozzi, Padma Prabodh Varanasi, Michael C. Fryan, Kenneth J. Welch, Stanley J. Flashinski, Debra A. Strasser
  • Patent number: 7618641
    Abstract: Vaccines directed against antigens such as membrane proteins from pathogens or tumor cells are disclosed. Also described are methods of forming reconstituted viral membranes, with membrane fusion activity, which are lipid bilayer membranes preferably containing natural lipids of a virus, a viral fusion protein, one or more optional further antigens as well as amphiphilic adjuvants. Pharmaceutical compositions including such reconstituted viral membranes are also described.
    Type: Grant
    Filed: June 18, 2004
    Date of Patent: November 17, 2009
    Assignee: Bestewil Holding B.V.
    Inventors: Antonius Johannes Hendrikus Stegmann, Jan Christiaan Wilschut, Johannes Henricus Gerardus Van Berkum
  • Patent number: 7615539
    Abstract: The invention relates to a nucleic acid-lipophilic conjugates and methods for modulating an immune response using the conjugates. The lipophilic moiety associated with an immunostimulatory nucleic acid.
    Type: Grant
    Filed: September 27, 2004
    Date of Patent: November 10, 2009
    Assignees: Coley Pharmaceutical Group, Inc., Coley Pharmaceutical GmbH
    Inventors: Eugen Uhlmann, Jörg Vollmer, Arthur M. Krieg
  • Patent number: 7601331
    Abstract: It is provided a Near Infrared Sensitive (NIR-sensitive) nanoparticle complex comprising a NIR-sensitive nanoparticle and surfactant(s) adsorbed on the nanoparticle, wherein the surfactant is at least one surfactant selected from: wherein X=1-9; Y=0-9; n=0-9; Z=1-9; W=0-9; m=0-9; each of R1, R2, R3 and R4, if present, is H, substituted or unsubstituted C1-C6 alkyl, substituted or unsubstituted C1-C6 aryl, HS, COOH, NH2 or OH; R5 is COOH, NH2 or OH; with the proviso that n+m is <10; (b) an amino acid having the structure in (a), wherein X=1; Y=2; Z=1; W=1; R1, R2 and R4 are not present; R3 is NH2; and R5 is COOH; or (c) a peptide, wherein the peptide comprise at least one amino acid (b). Further, it is provided a NIR-sensitive nanoparticle complex(es) having biomolecule(s), for example drug(s), loaded on the surfactant(s).
    Type: Grant
    Filed: November 10, 2004
    Date of Patent: October 13, 2009
    Assignee: National University of Singapore
    Inventors: Gan Moog Chow, Mei Chee Tan, Lei Ren, Jackie Yi-Ru Ying
  • Publication number: 20090214606
    Abstract: The present invention relates to antimicrobial, porous particles, especially porous, non-platelet-like SiO2 particles, comprising an organic, or inorganic antimicrobial compound, or composition, with the proviso that the porous particles are not porous SiOz flakes, wherein 0.70<z<2.0, especially 0.95<z<2.0, which provide enhanced (long term) antimicrobial efficacy.
    Type: Application
    Filed: May 3, 2006
    Publication date: August 27, 2009
    Inventors: Patrice Bujard, Holger Hoppe
  • Patent number: 7534449
    Abstract: Polymeric delivery devices have been developed which combine high loading/high density of molecules to be delivered with the option of targeting. As used herein, “high density” refers to microparticles having a high density of ligands or coupling agents, which is in the range of 1000-10,000,000, more preferably between 10,000 and 1,000,000 ligands per square micron of microparticle surface area. A general method for incorporating molecules into the surface of biocompatible polymers using materials with an HLB of less than 10, more preferably less than 5, such as fatty acids, has been developed. Because of its ease, generality and flexibility, this method has widespread utility in modifying the surface of polymeric materials for applications in drug delivery and tissue engineering, as well other other fields.
    Type: Grant
    Filed: June 30, 2005
    Date of Patent: May 19, 2009
    Assignee: Yale University
    Inventors: William Mark Saltzman, Tarek Fahmy, Peter Fong
  • Patent number: 7534448
    Abstract: Polymeric microparticles have been developed which encapsulate therapeutic compounds such as drugs, cellular materials or components, and antigens, and can have targeting ligands directly bound to the microparticle surface. Preferred applications include use in tissue engineering matrices, wound dressings, bone repair or regeneration materials, and other applications where the microparticles are retained at the site of application or implantation. Another preferred application is in the use of microparticles to deliver anti-proliferative agents to the lining of blood vessels following angioplasty, transplantation or bypass surgery to prevent or decrease restenosis, and in cancer therapy. In still another application, the microparticles are used to treat or prevent macular degeneration when administered to the eye, where agents such as complement inhibitors are administered.
    Type: Grant
    Filed: June 30, 2005
    Date of Patent: May 19, 2009
    Assignee: Yale University
    Inventors: William Mark Saltzman, Tarek Fahmy, Peter Fong, Chris Breuer
  • Patent number: 7531187
    Abstract: A synergistic insecticidal composition is formed containing a Chloronicotynyle compound and a Pyrethroids compound. The Chloronicotynyle compound is provided in an amount preferably ranging from 0.1 to 5.0% by weight of the synergistic insecticidal composition. The Pyrethroids compound is provided in an amount preferably ranging from 1 to 60% by weight of the synergistic insecticidal composition. The synergistic insecticidal composition also preferably includes 35 to 98.90% by weight of conventional agriculturally acceptable carrier(s) and/or excipients.
    Type: Grant
    Filed: July 13, 2004
    Date of Patent: May 12, 2009
    Assignee: United Phosphorus, Ltd.
    Inventors: Prakash Mahadev Jadhav, Jaidev Rajnikant Shroff
  • Publication number: 20090081262
    Abstract: The invention relates to process for coating a solid, water-insoluble particulate matter, with a metal oxide comprising: (a) contacting the solid water-insoluble particulate matter with a cationic additive in an aqueous medium to obtain a dispersion of said particulate matter having a positive zeta potential; (b) coating the solid water-insoluble particulate matter by precipitation of a metal oxide salt onto the surface of the particulate matter, forming a metal oxide layer thereon; and (c) aging said coating layer The invention further relates to coated particulate matter obtained by the process and to compositions comprising solid, water-insoluble particulate matter, coated by a metal oxide layer, the particulate matter being a dermatological active agent or a pesticide. The invention additionally relates to methods of treating a surface condition in a subject using compositions comprising solid, water insoluble dermatologically active agent, coated by a metal oxide layer.
    Type: Application
    Filed: August 2, 2006
    Publication date: March 26, 2009
    Applicant: SOL-GEL TECHNOLOGIES LTD.
    Inventors: Ofer Toledano, Hanan Sertchook, Natalia Loboda, Hiam Bar-Simantov
  • Patent number: 7504112
    Abstract: The present invention provides improved chlortetracycline-containing animal feed compositions and processes and apparatuses for their preparation. In certain embodiments, raw fermentation broth comprising chlortetracycline is divided into two portions. The first portion is mixed with a compound that complexes chlortetracycline. The second portion is acidified and the solids are removed. The acidified liquid is treated with a complexing agent to produced a chlortetracycline complex. The first and second portions thus treated are then mixed and the mixture is passed on to a filter press or other means for separation of the solids to produce a wet cake comprising complexed chlortetracycline. In alternative embodiments, the second portion may be acidified and filtered and admixed with the first portion prior to the complexing step. The resulting mixture is passed on to a filter press or other means for separation of the solids.
    Type: Grant
    Filed: December 2, 2004
    Date of Patent: March 17, 2009
    Assignee: Pennfield Oil Company
    Inventor: Willis L. Winstrom
  • Patent number: 7498028
    Abstract: The invention relates to surfactant-free reagent spheres useful for biological tests particularly those involving antigen/antibody reactions.
    Type: Grant
    Filed: June 14, 2007
    Date of Patent: March 3, 2009
    Inventors: Susan Goertz, Paul Hemmes
  • Patent number: 7473685
    Abstract: Dry flow, low compact, dust free, soluble granules of phosphoroamidothioates, preferably acephate, are produced by the process of 1) pre-mixing technical grade phosphoroamidothioate with specified adjuvants and other inert ingredients; 2) grinding to produce a ground product having a preferred particle size of 5 microns to 10 microns; 3) post-mixing; 4) granulating; 5) drying; 6) sizing to required length, preferably 1.5 to 3.0 mm; 7) and sieving to remove the fines to get the desired dust free soluble granule.
    Type: Grant
    Filed: February 18, 2005
    Date of Patent: January 6, 2009
    Assignee: United Phosphorus, Ltd.
    Inventors: Prakash Mahadeo Jadhav, Rajju Devidas Shroff
  • Patent number: 7468194
    Abstract: Disclosed in certain embodiments is a method of treating infections of an interior part of the human or animal body, comprising administering to said interior body part, a pharmaceutical preparation comprising a particulate carrier and an effective amount of an agent selected from the group consisting of an antiseptic agent, a wound-healing promoting agent and a combination thereof, to treat an infection at said interior body part.
    Type: Grant
    Filed: May 25, 2000
    Date of Patent: December 23, 2008
    Assignee: Euro-Celtique, S.A.
    Inventors: Wolfgang Fleischer, Karen Reimer
  • Publication number: 20080292674
    Abstract: Bioactive agrichemical concentrates and compositions having improved bioactivity comprising combinations of acid solutions and conventional bioactive agrichemical actives or formulations.
    Type: Application
    Filed: May 19, 2008
    Publication date: November 27, 2008
    Inventor: Joseph J. Crudden
  • Publication number: 20080292676
    Abstract: Bioactive agrichemical concentrates and compositions having improved bioactivity comprising metal-acid solutions.
    Type: Application
    Filed: May 19, 2008
    Publication date: November 27, 2008
    Inventor: Joseph J. Crudden
  • Publication number: 20080292673
    Abstract: Bioactive agrichemical concentrates and compositions having improved bioactivity comprising combinations of acid solutions and conventional bioactive agrichemical actives or formulations.
    Type: Application
    Filed: May 19, 2008
    Publication date: November 27, 2008
    Inventor: Joseph J. Crudden
  • Patent number: 7449196
    Abstract: An anti-cancer composition having biocompatible materials, which can selectively exploit chemical variations between normal cells and cancer cells to inhibit or prevent the proliferation of cancerous cells and methods of use.
    Type: Grant
    Filed: July 9, 2004
    Date of Patent: November 11, 2008
    Inventor: Robert Sabin
  • Patent number: 7445791
    Abstract: A synergistic insecticidal composition is prepared by combining a Chloronicotynyle compound and an Organophosphorus (OP) compound. The preferred synergistically effective amount of the Chloronicotynyle compounds is an amount preferably ranging from 0.1 to 5% by weight of the composition. The preferred synergistically effective amount of the Organophosphorus (OP) compounds is an amount preferably ranging from 30 to 75% by weight of the composition. The composition also preferably includes 69.9 to 20% by weight of conventional agriculturally acceptable carrier(s) and/or excipient.
    Type: Grant
    Filed: July 12, 2004
    Date of Patent: November 4, 2008
    Assignee: United Phosphorus, Ltd.
    Inventors: Prakash Mahadev Jadhav, Jaidev Rajnikant Shroff
  • Publication number: 20080254084
    Abstract: The invention relates to antimicrobial preparations which comprise octenidine dihydrochloride in liposomes. The invention additionally relates to a process for manufacturing the preparations and to the use of phospholipids for manufacturing antimicrobial preparations which comprise octenidine dihydrochloride. The preparations show a low cytoxicity.
    Type: Application
    Filed: September 12, 2006
    Publication date: October 16, 2008
    Applicant: Air Liquide Sante (International)
    Inventors: Sabine Behrends, Jorg Siebert, Mona Golombiewski, Axel Kramer, Gerald Muller
  • Publication number: 20080220038
    Abstract: There is disclosed method of killing nematodes comprising the step of applying an effective amount of a nematicidal composition comprising a terpene component and compositions suitable for use in the method. The terpene component is preferably in association with water, either as a solution or a suspension. An excipient may also be included, which is suitably hollow glucan particles which encapsulate the terpene component.
    Type: Application
    Filed: January 24, 2005
    Publication date: September 11, 2008
    Inventors: Lanny Franklin, Elizabeth Cloud, Lanna Knapp, Gary Ostroff
  • Patent number: 7423004
    Abstract: Disclosed is a water-dispersible solid composition of a sparingly water-soluble compound in a particulatable lipidic carrier, methods for the preparation and use of the same. The compositions of this intention provide improved solubility and dissolution characteristics and enhanced bioavailability of the sparingly soluble compound.
    Type: Grant
    Filed: January 30, 2004
    Date of Patent: September 9, 2008
    Assignee: SmithKline Beecham Corporation
    Inventors: Kamlesh H. Patel, Raviraj S. Pillai
  • Patent number: 7419687
    Abstract: A delivery vehicle for a silver ion source such as silver nitrate and the like, suitable for use in the treatment of menorrhagia, comprises a plurality of physiologically inert beads bearing a tissue cauterizing amount of a silver ion source. Preferably the beads are made of a physiologically inert polymer, ceramic or stainless steel. The silver ion source preferably is silver nitrate and can be substantially pure silver nitrate, or can comprise silver nitrate in combination with a physiologically tolerable binder or a diluent. Suitable binders include physiologically tolerable synthetic polymeric binders, polysaccharide binders, and the like. Diluents can include other salt materials such as potassium nitrate. The beads are useful in treating menorrhagia of a mammalian uterus. The beads can be delivered to the uterus via a catheter, and are distributed throughout the uterine cavity by uterine massage or like expedient. Silver ions are delivered to the endometrium and cause necrosis of the endometrial tissue.
    Type: Grant
    Filed: April 16, 2004
    Date of Patent: September 2, 2008
    Assignee: Ablation Products LLC
    Inventor: Robert S. Neuwirth
  • Publication number: 20080160059
    Abstract: The present invention refers to a fungicide/bactericide formulation comprising oxytetracycline hydrochloride and copper oxychloride for use in plants.
    Type: Application
    Filed: November 7, 2007
    Publication date: July 3, 2008
    Applicant: Quimica Agronomica de Mexico
    Inventor: Miguel Enrique Alvarado Licon
  • Patent number: 7378104
    Abstract: Particles (10) for controlling, treating, feeding of aquatic invertebrate filter feeding organisms such as mussels, clams, oysters and insect larvae comprising a biologically active ingredient (13) embedded within or surrounded by an innocuous carrier material (12). The organism effectively concentrates the active ingredient within its body by feeding on the particles, thereby reducing the total amount of active ingredient required to be used.
    Type: Grant
    Filed: January 19, 2001
    Date of Patent: May 27, 2008
    Assignee: BioBullets Limited
    Inventors: David Aldridge, Geoffrey Dillwyn Moggridge
  • Patent number: 7354596
    Abstract: A delivery system for delivering an anti-microbial agent to a surface in a time release manner. The delivery system includes one or more polymeric particles (e.g., microspheres, core/shell particles, latexes, porogens, cryogenically ground beads, condensation polymer particles, flakes, etc.) and at least anti-microbial agent attached thereto. The anti-microbial agents may or may not be soluble in the polymeric particle or in the monomeric precursor used to make the polymeric particle. The anti-microbial agent can be incorporated into the microsphere using either a post polymerization addition process or an in situ addition process. The delivery system can be fashioned to provide characteristics that are application specific. Examples of such delivery systems include but are not limited to substrates (such as tapes, sheets of material and the like) coated with the releasably loaded polymeric particles, sprayable dispersions or suspensions of these polymeric particles and the like.
    Type: Grant
    Filed: May 1, 1998
    Date of Patent: April 8, 2008
    Assignee: 3M Innovative Properties Company
    Inventors: John P. Banovetz, Jeffry L. Jacobs
  • Patent number: 7341739
    Abstract: The small particle liposome aerosol compounds and methods of treatment of the present invention involve lipid- or water soluble anti-cancer drugs incorporated into liposomes. The liposomes are administered in aqueous dispersions from a jet nebulizer to the respiratory tract of an individual. Various anti-cancer drugs may be used, including 20-S-Camptothecin, 9-Nitro-camptothecin, 9-Amino-camptothecin, 10, 11-methylenedioxy-camptothecin and taxol or its derivatives. Administration of these drugs by inhalation provides faster and more efficient absorption of the anticancer drug than does intramuscular administration or oral administration.
    Type: Grant
    Filed: May 11, 2004
    Date of Patent: March 11, 2008
    Assignee: Research Development Foundation
    Inventors: Beppino C. Giovanella, J. Vernon Knight, J. Clifford Waldrep, Nadezhda Koshkina, Brian Gilbert, Clyde W. Wellen
  • Patent number: 7285289
    Abstract: The present invention relates to nanoparticle vaccines comprised of a carrier, particularly polymerized lipids, having multiple copies of an antigen or combinations of different antigens displayed on the carrier. Such antigen-displaying nanoparticles may also display a targeting molecule on its surface in order to direct it to a specific site or cell type to optimize a desired immune response. The present invention also relates to encapsulating an antigen or combinations of different antigens within such nanoparticles, with or without a targeting molecule displayed on its surface. The antigens used in this invention are effective to produce an immune response against a variety of pathological conditions.
    Type: Grant
    Filed: April 14, 2003
    Date of Patent: October 23, 2007
    Inventors: Jon O. Nagy, Robert F. Bargatze, John W. Jutila, Jim E. Cutler, Pati M. Glee
  • Patent number: 7282212
    Abstract: There are described a method for the control of wood pests which comprises applying to the pests or to their habitat a pesticidally active amount of a pesticidal composition comprising, as active ingredient, at least a compound of formula in free form or in the form of an agrochemically acceptable salt, and at least one adjuvant; the corresponding use of those compounds, pesticidal compositions whose active ingredient is selected from those compounds, a process for the preparation of such compositions, the use of such compositions, and plant propagation material accordingly protected against pest attack.
    Type: Grant
    Filed: August 27, 2001
    Date of Patent: October 16, 2007
    Assignee: Syngenta Crop Protection, Inc.
    Inventor: Robert Senn
  • Patent number: 7273567
    Abstract: A composition for energy-controlled generation and release of at least one gas, which includes an energy-activated catalyst capable of being activated by electromagnetic energy, and a solid or a liquid containing anions capable of being oxidized by the activated catalyst or reacted with species generated during activation of the catalyst to generate at least one gas. The composition, when exposed to electromagnetic energy, is capable of generating and releasing the gas after activation of the catalyst and oxidation or reaction of the anions.
    Type: Grant
    Filed: November 24, 1999
    Date of Patent: September 25, 2007
    Assignee: MicroActive Corp.
    Inventors: Stephen T. Wellinghoff, Joel J. Kampa, Michael D. Lelah, Sumner A. Barenberg, Peter N. Gray, Hong Dixon